American Academy of CME

Best of ACTHIV® 2023: Approaches to ART Optimization in the Virally Suppressed Patient

Overview / Abstract:	Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module will provide guidance on when to consider an ART change in a virally suppressed person, and the use of 2-drug regimens. Assess when to consider ART change in a virally suppressed person Appraise when a 2-drug regimen is appropriate, and when it may be contraindicated
Expiration	Sep 15, 2024
Discipline(s)	Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME
Format	Online
Credits / Hours	.50
Accreditation	ACCME
Presenters / Authors / Faculty	Gretchen Snoeyenbos-Newman,MD
Sponsors / Supporters / Grant Providers	Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck, Theratechnologies, and ViiV Healthcare.
Keywords / Search Terms	American Academy of CME Viral Suppression HIV Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map